https://www.selleckchem.com/pr....oducts/prt062607-p50
Finally, we observed that the upregulating effector CD8 T cell is associated with the better therapeutic effect of anti-PD-L1 therapy post Tregs depletion. Anti-PD-L1 treatment upregulates Tregs frequency and proliferation in tumor model, and the depletion of Tregs may be a useful adjuvant strategy for anti-PD-L1 therapy of cervical cancer. Anti-PD-L1 treatment upregulates Tregs frequency and proliferation in tumor model, and the depletion of Tregs may be a useful adjuvant strategy for anti-PD-L1 therapy of cervical cancer
Like
Comment
Share
